Stocks · Health care · Pharmaceutical Preparations

Vertex Pharmaceuticals

VRTX Clue Score74
United States Fiscal year ends December CIK 0000875320 Results filed 2 Nov 2026

What the insiders did Scheduled selling only

Insider
Date
Role
Action
Shares
Price
Amount
Jeffrey M Leiden
4 Dec 2025
Executive Chairman
Exercised, kept
1
$91.05
$91.05

What was left out

Form 4 filings counted 110
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 67
Sales straight out of an exercise 26
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 548,112
History held since 4 Oct 2006